| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-08 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-07 |